Adaptive Biotechnologies Corporation · NASDAQ:ADPT

Rubinstein Julie sold 57,180 Adaptive Biotechnologies Corporation shares (Form 4)

Traded Apr 22 to Apr 24, 2026 · Filed Apr 24, 2026

From Apr 22 to Apr 24, 2026, Rubinstein Julie (President and COO) sold 57,180 Adaptive Biotechnologies Corporation shares at an average US$13.96 for US$798K under a trading plan, leaving 382,132 shares. Filed Apr 24, 2026 (Form 4).

Sold
57,180 shares
Price
US$13.96 average (US$13.74 to US$14.13)
Value
US$798K
Holding after
382,132 shares
Trading plan
Yes (Made under a plan set in advance)
Role
President and COO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 22, 2026Common StockOption exercise14,722US$8.46409,868Direct
Apr 22, 2026Common StockSale19,060US$14.13390,808Direct
Apr 23, 2026Common StockOption exercise14,722US$8.46405,530Direct
Apr 23, 2026Common StockSale19,060US$13.74386,470Direct
Apr 24, 2026Common StockOption exercise14,722US$8.46401,192Direct
Apr 24, 2026Common StockSale19,060US$14.02382,132Direct

Source

View original at SEC

Related